The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Principles for targeting RNA with drug-like small molecules
Open accessAbstract
RNA molecules are essential for cellular information transfer and gene regulation, and RNAs have been implicated in many human diseases. Messenger and non-coding RNAs contain highly structured elements, and evidence suggests that many of these structures are important for function. Targeting these RNAs with small molecules offers opportunities to therapeutically modulate numerous cellular processes, including those linked to 'undruggable' protein targets. Despite this promise, there is currently only a single class of human-designed small molecules that target RNA used clinically — the linezolid antibiotics. However, a growing number of small-molecule RNA ligands are being identified, leading to burgeoning interest in the field. Here, we discuss principles for discovering small-molecule drugs that target RNA and argue that the overarching challenge is to identify appropriate target structures — namely, in disease-causing RNAs that have high information content and, consequently, appropriate ligand-binding pockets. If focus is placed on such druggable binding sites in RNA, extensive knowledge of the typical physicochemical properties of drug-like small molecules could then enable small-molecule drug discovery for RNA targets to become (only) roughly as difficult as for protein targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,199
Landscape of transcription in human cells
Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., et al. (2012) · Nature · doi:10.1038/nature11233 · Cited by 5,187
GENCODE: The reference human genome annotation for The ENCODE Project
Harrow, J., Frankish, A., Gonzalez, J. M., Tapanari, E., Diekhans, M., Kokocinski, F., Aken, B. L., Barrell, D., Zadissa, A., Searle, S., et al. (2012) · Genome Research · doi:10.1101/gr.135350.111 · Cited by 4,585
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
The Noncoding RNA Revolution—Trashing Old Rules to Forge New Ones
Cech, T. R., & Steitz, J. A. (2014) · Cell · doi:10.1016/j.cell.2014.03.008 · Cited by 2,524
A comprehensive map of molecular drug targets
Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., et al. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.230 · Cited by 2,427
Quantifying the chemical beauty of drugs
Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012) · Nature Chemistry · doi:10.1038/nchem.1243 · Cited by 2,242
Ribosome-targeting antibiotics and mechanisms of bacterial resistance
Wilson, D. N. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3155 · Cited by 1,054
Non-coding RNAs as drug targets
Matsui, M., & Corey, D. R. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.117 · Cited by 1,032
Tinoco, I., & Bustamante, C. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3001 · Cited by 1,010
Information content of binding sites on nucleotide sequences
Schneider, T. D., Stormo, G. D., Gold, L., & Ehrenfeucht, A. (1986) · Journal of Molecular Biology · doi:10.1016/0022-2836(86)90165-8 · Cited by 945
Crooke, S. T., Witztum, J. L., Bennett, C. F., & Baker, B. F. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.004 · Cited by 841
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
Doak, B. C., Over, B., Giordanetto, F., & Kihlberg, J. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.013 · Cited by 835
Regulation of translation via mRNA structure in prokaryotes and eukaryotes
Kozak, M. (2005) · Gene · doi:10.1016/j.gene.2005.06.037 · Cited by 747
Targeting noncoding RNAs in disease
Adams, B. D., Parsons, C., Walker, L., Zhang, W. C., & Slack, F. J. (2017) · Journal of Clinical Investigation · doi:10.1172/jci84424 · Cited by 673
RNA motif discovery by SHAPE and mutational profiling (SHAPE-MaP)
Siegfried, N. A., Busan, S., Rice, G. M., Nelson, J. A. E., & Weeks, K. M. (2014) · Nature Methods · doi:10.1038/nmeth.3029 · Cited by 654
Self-citationTargeting RNA with Small Molecules
Thomas, J. R., & Hergenrother, P. J. (2008) · Chemical Reviews · doi:10.1021/cr0681546 · Cited by 647
Distinguishing protein-coding and noncoding genes in the human genome
Clamp, M., Fry, B., Kamal, M., Xie, X., Cuff, J., Lin, M. F., Kellis, M., Lindblad-Toh, K., & Lander, E. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709013104 · Cited by 624
Multiple evidence strands suggest that there may be as few as 19 000 human protein-coding genes
Ezkurdia, I., Juan, D., Rodriguez, J. M., Frankish, A., Diekhans, M., Harrow, J., Vazquez, J., Valencia, A., & Tress, M. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu309 · Cited by 549
Riboswitch diversity and distribution
McCown, P. J., Corbino, K. A., Stav, S., Sherlock, M. E., & Breaker, R. R. (2017) · RNA · doi:10.1261/rna.061234.117 · Cited by 467
Sharp, P. A. (2009) · Cell · doi:10.1016/j.cell.2009.02.007 · Cited by 455
Linezolid: The First Oxazolidinone Antimicrobial
Moellering, R. C. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-2-200301210-00015 · Cited by 455
Cornerstones of CRISPR–Cas in drug discovery and therapy
Fellmann, C., Gowen, B. G., Lin, P.-C., Doudna, J. A., & Corn, J. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.238 · Cited by 443
SMN2 splice modulators enhance U1–pre-mRNA association and rescue SMA mice
Palacino, J., Swalley, S. E., Song, C., Cheung, A. K., Shu, L., Zhang, X., Van Hoosear, M., Shin, Y., Chin, D. N., Keller, C. G., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1837 · Cited by 432
eIF3 targets cell-proliferation messenger RNAs for translational activation or repression
Lee, A. S. Y., Kranzusch, P. J., & Cate, J. H. D. (2015) · Nature · doi:10.1038/nature14267 · Cited by 427
Pocketome via Comprehensive Identification and Classification of Ligand Binding Envelopes
An, J., Totrov, M., & Abagyan, R. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400159-mcp200 · Cited by 408
Selective small-molecule inhibition of an RNA structural element
Howe, J. A., Wang, H., Fischmann, T. O., Balibar, C. J., Xiao, L., Galgoci, A. M., Malinverni, J. C., Mayhood, T., Villafania, A., Nahvi, A., et al. (2015) · Nature · doi:10.1038/nature15542 · Cited by 407
Smola, M. J., Rice, G. M., Busan, S., Siegfried, N. A., & Weeks, K. M. (2015) · Nature Protocols · doi:10.1038/nprot.2015.103 · Cited by 398
Self-citationResistance to Linezolid Caused by Modifications at Its Binding Site on the Ribosome
Long, K. S., & Vester, B. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05702-11 · Cited by 375
Pseudoknots: RNA Structures with Diverse Functions
Staple, D. W., & Butcher, S. E. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030213 · Cited by 367
Accurate SHAPE-directed RNA secondary structure modeling, including pseudoknots
Hajdin, C. E., Bellaousov, S., Huggins, W., Leonard, C. W., Mathews, D. H., & Weeks, K. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219988110 · Cited by 331
Self-citationLinezolid: The First Oxazolidinone Antimicrobial
Paterson, D. L., Pasculle, A. W., & McCurry, K. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00017 · Cited by 328
RNA recognition by Tat-derived peptides: Interaction in the major groove?
Weeks, K. M., & Crothers, D. M. (1991) · Cell · doi:10.1016/0092-8674(81)90020-9 · Cited by 320
Self-citationWilson, D. N., Schluenzen, F., Harms, J. M., Starosta, A. L., Connell, S. R., & Fucini, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804276105 · Cited by 318
The Emerging Role of RNA as a Therapeutic Target for Small Molecules
Connelly, C. M., Moon, M. H., & Schneekloth, J. S. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.05.021 · Cited by 316
Cell permeability beyond the rule of 5
Matsson, P., Doak, B. C., Over, B., & Kihlberg, J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.013 · Cited by 297
Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble
Stelzer, A. C., Frank, A. T., Kratz, J. D., Swanson, M. D., Gonzalez-Hernandez, M. J., Lee, J., Andricioaei, I., Markovitz, D. M., & Al-Hashimi, H. M. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.596 · Cited by 291
Coenzyme recognition and gene regulation by a flavin mononucleotide riboswitch
Serganov, A., Huang, L., & Patel, D. J. (2009) · Nature · doi:10.1038/nature07642 · Cited by 289
Recent Advances in Developing Small Molecules Targeting RNA
Guan, L., & Disney, M. D. (2012) · ACS Chemical Biology · doi:10.1021/cb200447r · Cited by 280
Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery
Pérot, S., Sperandio, O., Miteva, M. A., Camproux, A.-C., & Villoutreix, B. O. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.05.015 · Cited by 276
Lin, A. H., Murray, R. W., Vidmar, T. J., & Marotti, K. R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2127 · Cited by 261
Pervasive Regulatory Functions of mRNA Structure Revealed by High-Resolution SHAPE Probing
Mustoe, A. M., Busan, S., Rice, G. M., Hajdin, C. E., Peterson, B. K., Ruda, V. M., Kubica, N., Nutiu, R., Baryza, J. L., & Weeks, K. M. (2018) · Cell · doi:10.1016/j.cell.2018.02.034 · Cited by 258
Self-citationKondo, Y., Oubridge, C., van Roon, A.-M. M., & Nagai, K. (2015) · eLife · doi:10.7554/elife.04986 · Cited by 255
Informational Complexity and Functional Activity of RNA Structures
Carothers, J. M., Oestreich, S. C., Davis, J. H., & Szostak, J. W. (2004) · Journal of the American Chemical Society · doi:10.1021/ja031504a · Cited by 236
Smola, M. J., Christy, T. W., Inoue, K., Nicholson, C. O., Friedersdorf, M., Keene, J. D., Lee, D. M., Calabrese, J. M., & Weeks, K. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600008113 · Cited by 227
Self-citationBinding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiers
Sivaramakrishnan, M., McCarthy, K. D., Campagne, S., Huber, S., Meier, S., Augustin, A., Heckel, T., Meistermann, H., Hug, M. N., Birrer, P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01559-4 · Cited by 226
Design of a small molecule against an oncogenic noncoding RNA
Velagapudi, S. P., Cameron, M. D., Haga, C. L., Rosenberg, L. H., Lafitte, M., Duckett, D. R., Phinney, D. G., & Disney, M. D. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523975113 · Cited by 218
Liang, X.-H., Shen, W., Sun, H., Migawa, M. T., Vickers, T. A., & Crooke, S. T. (2016) · Nature Biotechnology · doi:10.1038/nbt.3589 · Cited by 212
Precise small-molecule recognition of a toxic CUG RNA repeat expansion
Rzuczek, S. G., Colgan, L. A., Nakai, Y., Cameron, M. D., Furling, D., Yasuda, R., & Disney, M. D. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2251 · Cited by 209
Targeting Protein-Protein Interaction by Small Molecules
Jin, L., Wang, W., & Fang, G. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-140028 · Cited by 195
RNA Structure: Advances and Assessment of 3D Structure Prediction
Miao, Z., & Westhof, E. (2017) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-070816-034125 · Cited by 188
Fauman, E. B., Rai, B. K., & Huang, E. S. (2011) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2011.05.020 · Cited by 181
RNA Structure Duplications and Flavivirus Host Adaptation
Villordo, S. M., Carballeda, J. M., Filomatori, C. V., & Gamarnik, A. V. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.01.002 · Cited by 181
Detection of RNA–Protein Interactions in Living Cells with SHAPE
Smola, M. J., Calabrese, J. M., & Weeks, K. M. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00977 · Cited by 171
Self-citationConformational inhibition of the hepatitis C virus internal ribosome entry site RNA
Parsons, J., Castaldi, M. P., Dutta, S., Dibrov, S. M., Wyles, D. L., & Hermann, T. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.217 · Cited by 166
Structural Rearrangements of HIV-1 Tat-responsive RNA upon Binding of Neomycin B
Faber, C., Sticht, H., Schweimer, K., & ROSCH, P. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000920200 · Cited by 165
Small Molecule Inhibition of microRNA-210 Reprograms an Oncogenic Hypoxic Circuit
Costales, M. G., Haga, C. L., Velagapudi, S. P., Childs-Disney, J. L., Phinney, D. G., & Disney, M. D. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b11273 · Cited by 164
Exploring RNA Structural Codes with SHAPE Chemistry
Weeks, K. M., & Mauger, D. (2011) · Accounts of Chemical Research · doi:10.1021/ar200051h · Cited by 160
Self-citationXue, Z., Hennelly, S., Doyle, B., Gulati, A. A., Novikova, I. V., Sanbonmatsu, K. Y., & Boyer, L. A. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.08.010 · Cited by 159
Liang, X., Sun, H., Shen, W., Wang, S., Yao, J., Migawa, M. T., Bui, H., Damle, S. S., Riney, S., Graham, M. J., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx632 · Cited by 158
Small molecules targeting viral RNA
Hermann, T. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1373 · Cited by 154
Park, S., Kim, Y., & Park, H. (2011) · Journal of the American Chemical Society · doi:10.1021/ja1098325 · Cited by 150
Mei, H., Mack, D. P., Galan, A. A., Halim, N. S., Heldsinger, A. A., Loo, J. A., Moreland, D. W., Sannes, K. A., Sharmeen, L., Truong, H. N., et al. (1997) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(97)00064-3 · Cited by 148
Sztuba-Solińska, J., Shenoy, S. R., Gareiss, P. C., Krumpe, L. R. H., Grice, S. F. J. L., O’Keefe, B. R., & Schneekloth, J. S. (2014) · Journal of the American Chemical Society · doi:10.1021/ja502754f · Cited by 144
Morgan, B. S., Forte, J. E., Culver, R. N., Zhang, Y., & Hargrove, A. E. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201707641 · Cited by 137
Adaptive Ligand Binding by the Purine Riboswitch in the Recognition of Guanine and Adenine Analogs
Gilbert, S. D., Reyes, F. E., Edwards, A. L., & Batey, R. (2009) · Structure · doi:10.1016/j.str.2009.04.009 · Cited by 133
Nguyen, L., Luu, L. M., Peng, S. I., Serrano, J. F., Chan, H. Y. E., & Zimmerman, S. C. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b09266 · Cited by 125
Identifying druggable disease-modifying gene products
Dixon, S. J., & Stockwell, B. R. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.08.003 · Cited by 119
The Coding Region of the HCV Genome Contains a Network of Regulatory RNA Structures
Pirakitikulr, N., Kohlway, A. S., Lindenbach, B. D., & Pyle, A. M. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.01.024 · Cited by 118
Inhibition of translation by RNA–small molecule interactions
Harvey, I., Garneau, P., & Pelletier, J. (2002) · RNA · doi:10.1017/s135583820202633x · Cited by 114
Solution structure of the pseudoknot of SRV-1 RNA, involved in ribosomal frameshifting
Michiels, P. J. A., Versleijen, A. A. M., Verlaan, P. W. G., Pleij, C. W. A., Hilbers, C. W., & Heus, H. A. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4823 · Cited by 107
Warner, K. D., Homan, P., Weeks, K. M., Smith, A. G., Abell, C., & Ferré-D’Amaré, A. R. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.03.007 · Cited by 92
Self-citationHow drug-like are ‘ugly’ drugs: do drug-likeness metrics predict ADME behaviour in humans?
Ritchie, T. J., & Macdonald, S. J. F. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.01.007 · Cited by 88
Anti-frameshifting Ligand Reduces the Conformational Plasticity of the SARS Virus Pseudoknot
Ritchie, D. B., Soong, J., Sikkema, W. K. A., & Woodside, M. T. (2014) · Journal of the American Chemical Society · doi:10.1021/ja410344b · Cited by 83
Crystal Structure of Human Riboflavin Kinase Reveals a β Barrel Fold and a Novel Active Site Arch
Karthikeyan, S., Zhou, Q., Mseeh, F., Grishin, N. V., Osterman, A. L., & Zhang, H. (2003) · Structure · doi:10.1016/s0969-2126(03)00024-8 · Cited by 82
Strategies for the Design of Rna-Binding Small Molecules
Aboul‐ela, F. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.149 · Cited by 81
Solution structure of an informationally complex high-affinity RNA aptamer to GTP
CAROTHERS, J. M., DAVIS, J. H., CHOU, J. J., & SZOSTAK, J. W. (2006) · RNA · doi:10.1261/rna.2251306 · Cited by 78
Small Molecules in Development for the Treatment of Spinal Muscular Atrophy
Calder, A. N., Androphy, E. J., & Hodgetts, K. J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00670 · Cited by 77
Howe, J. A., Xiao, L., Fischmann, T. O., Wang, H., Tang, H., Villafania, A., Zhang, R., Barbieri, C. M., & Roemer, T. (2016) · RNA Biology · doi:10.1080/15476286.2016.1216304 · Cited by 76
RNA as a small molecule druggable target
Rizvi, N. F., & Smith, G. F. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.10.052 · Cited by 71
Pri-miR-17-92a transcript folds into a tertiary structure and autoregulates its processing
Chakraborty, S., Mehtab, S., Patwardhan, A., & Krishnan‐Ghosh, Y. (2012) · RNA · doi:10.1261/rna.031039.111 · Cited by 70
Approaches to Validate and Manipulate RNA Targets with Small Molecules in Cells
Childs‐Disney, J. L., & Disney, M. D. (2015) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103910 · Cited by 67
Bandyopadhyay, S., Cahill, C. M., Balleidier, A., Huang, C., Lahiri, D. K., Huang, X., & Rogers, J. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065978 · Cited by 67
Chen, Y., Zubović, L., Yang, F., Godin, K. S., Pavelitz, T., Castellanos, J., Macchi, P., & Varani, G. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw177 · Cited by 66
An RNA structure-mediated, posttranscriptional model of human α-1-antitrypsin expression
Corley, M., Solem, A., Phillips, G., Lackey, L., Ziehr, B., Vincent, H. A., Mustoe, A. M., Ramos, S. B. V., Weeks, K. M., Moorman, N. J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706539114 · Cited by 64
Self-citationYildirim, I., Park, H., Disney, M. D., & Schatz, G. C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja3108627 · Cited by 61
Structural divergence creates new functional features in alphavirus genomes
Kutchko, K. M., Madden, E. A., Morrison, C. R., Plante, K. S., Sanders, W., Vincent, H. A., Cisneros, M. C. C., Long, K. M., Moorman, N. J., Heise, M. T., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky012 · Cited by 60
Hilimire, T. A., Chamberlain, J. M., Anokhina, V. S., Bennett, R. P., Swart, O., Myers, J. R., Ashton, J. M., Stewart, R. A., Featherston, A. L., Gates, K., et al. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00052 · Cited by 52
The solution structure of an essential stem-loop of human telomerase RNA
Leeper, T. C., Leulliot, N., & Varani, G. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg351 · Cited by 45
Slow molecular recognition by RNA
Gleitsman, K. R., Sengupta, R. N., & Herschlag, D. (2017) · RNA · doi:10.1261/rna.062026.117 · Cited by 43
Bonneau, É., & Legault, P. (2014) · Biochemistry · doi:10.1021/bi500826n · Cited by 29
Structural Constraints Identified with Covariation Analysis in Ribosomal RNA
Shang, L., Xu, W., Ozer, S., & Gutell, R. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039383 · Cited by 28
Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen
Prado, S., Beltrán, M., Coiras, M., Bedoya, L. M., Alcamı́, J., & Gallego, J. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.02.007 · Cited by 28
Modulation of the E. coli rpoH Temperature Sensor with Triptycene‐Based Small Molecules
Barros, S. A., Yoon, I., & Chenoweth, D. M. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601626 · Cited by 24
Cencig, S., Nanbru, C., Le, S., Gueydan, C., Huez, G. A., & Kruys, V. (2004) · Oncogene · doi:10.1038/sj.onc.1207017 · Cited by 20
Bonneau, É., Girard, N., Lemieux, S., & Legault, P. (2015) · RNA · doi:10.1261/rna.052076.115 · Cited by 19
Impact of RNA structure on ZFP36L2 interaction with luteinizing hormone receptor mRNA
Ball, C. B., Solem, A., Meganck, R. M., Laederach, A., & Ramos, S. B. V. (2017) · RNA · doi:10.1261/rna.060467.116 · Cited by 14
Cited by
Gene regulation by long non-coding RNAs and its biological functions
Statello, L., Guo, C.-J., Chen, L.-L., & Huarte, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00315-9 · Cited by 4,991
RNA sequencing: the teenage years
Stark, R., Grzelak, M., & Hadfield, J. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0150-2 · Cited by 1,915
The Structure and Function of DNA G-Quadruplexes
Spiegel, J., Adhikari, S., & Balasubramanian, S. (2020) · Trends in Chemistry · doi:10.1016/j.trechm.2019.07.002 · Cited by 920
“ments, it has previously been realised that increased planarity and strongly p-stacking compounds leads to off-target activity and that these molecules are generally difficult to improve via further medicinal chemistry [37].”
BackgroundNon-coding RNAs in disease: from mechanisms to therapeutics
Nemeth, K., Bayraktar, R., Ferracin, M., & Calin, G. A. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-023-00662-1 · Cited by 885
RNA-based therapeutics: an overview and prospectus
Zhu, Y., Zhu, L., Wang, X., & Jin, H. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05075-2 · Cited by 623
Metadata
- Authors
- Warner, K. D., Hajdin, C. E., & Weeks, K. M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2018-07-06
- Volume
- 17
- Issue
- 8
- Pages
- 547-558
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2820941669
- Cited by
- 749
- References
- 98
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.